New clinical opportunities for mineralocorticoid receptor antagonists: focus on antifibrotic effects

Mineralocorticoid receptor antagonists have been successfully used for many years to treat patients with primary hyperaldosteronism, refractory arterial hypertension and chronic heart failure. The increased interest in this drug in recent years is due to new information about its antifibrotic and an...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Natalia A. Dragomiretskaya, Aida I. Tarzimanova, Julia S. Kucherova, Valery I. Podzolkov
Formato: article
Lenguaje:RU
Publicado: "Consilium Medicum" Publishing house 2021
Materias:
R
Acceso en línea:https://doaj.org/article/e182cb868ad24da2ad9e2ac5a9fda2c2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!